Blockbuster interactions: are they bad for the patient?

Eur Heart J. 2012 Sep;33(17):2121-3. doi: 10.1093/eurheartj/ehs126. Epub 2012 May 21.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Clopidogrel
  • Coronary Artery Disease / drug therapy*
  • Cytochrome P-450 CYP3A / physiology*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Ticlopidine